Aesthetic Medical International Holdings Group Limited (FRA:3FMA)
Germany flag Germany · Delayed Price · Currency is EUR
0.0090
0.00 (0.00%)
Last updated: Jun 23, 2026, 8:00 AM CET

FRA:3FMA Statistics

Total Valuation

FRA:3FMA has a market cap or net worth of EUR 612,601. The enterprise value is 21.29 million.

Market Cap612,601
Enterprise Value 21.29M

Important Dates

The last earnings date was Thursday, May 7, 2026.

Earnings Date May 7, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) -11.39%
Owned by Insiders (%) 46.42%
Owned by Institutions (%) n/a
Float 6.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.01
PB Ratio -0.12
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.24
EV / EBITDA 2.71
EV / EBIT 33.00
EV / FCF n/a

Financial Position

The company has a current ratio of 0.31

Current Ratio 0.31
Quick Ratio 0.25
Debt / Equity n/a
Debt / EBITDA 4.40
Debt / FCF -14.67
Interest Coverage 0.60

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 0.66%
Return on Invested Capital (ROIC) 3.56%
Return on Capital Employed (ROCE) 6.36%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 77,279
Profits Per Employee -6,173
Employee Count1,139
Asset Turnover 1.45
Inventory Turnover 23.06

Taxes

In the past 12 months, FRA:3FMA has paid 3.57 million in taxes.

Income Tax 3.57M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -94.12% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -94.12%
50-Day Moving Average 0.04
200-Day Moving Average 0.08
Relative Strength Index (RSI) 23.22
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.13

Income Statement

In the last 12 months, FRA:3FMA had revenue of EUR 88.02 million and -7.03 million in losses. Loss per share was -0.15.

Revenue88.02M
Gross Profit 40.70M
Operating Income 637,460
Pretax Income -3.01M
Net Income -7.03M
EBITDA 3.53M
EBIT 637,460
Loss Per Share -0.15
Full Income Statement

Balance Sheet

The company has 10.98 million in cash and 34.17 million in debt, with a net cash position of -23.19 million.

Cash & Cash Equivalents 10.98M
Total Debt 34.17M
Net Cash -23.19M
Net Cash Per Share n/a
Equity (Book Value) -5.26M
Book Value Per Share -0.05
Working Capital -35.82M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.49 million and capital expenditures -840,570, giving a free cash flow of -2.33 million.

Operating Cash Flow -1.49M
Capital Expenditures -840,570
Depreciation & Amortization 3.07M
Net Borrowing 5.10M
Free Cash Flow -2.33M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 46.24%, with operating and profit margins of 0.72% and -7.38%.

Gross Margin 46.24%
Operating Margin 0.72%
Pretax Margin -3.42%
Profit Margin -7.38%
EBITDA Margin 4.01%
EBIT Margin 0.72%
FCF Margin n/a

Dividends & Yields

FRA:3FMA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -1,147.82%
FCF Yield -380.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:3FMA has an Altman Z-Score of -2.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.47
Piotroski F-Score 4